What Is Amlodipine (Norvasc)? Uses, Side Effects & Warnings

Amlodipine is a prescription calcium channel blocker (CCB) — specifically a dihydropyridine-type CCB — used primarily to treat hypertension (high blood pressure) and certain types of chest pain (angina). It is sold under the brand name Norvasc, though generic amlodipine has been widely available since the patent expired in 2007. Amlodipine tablets come in strengths of 2.5 mg, 5 mg, and 10 mg. Because of its exceptionally long half-life (35–50 hours), it provides 24-hour blood pressure control with a single daily dose.

What Amlodipine Is Used For

Amlodipine is FDA-approved for three indications. First, it is used to treat hypertension (high blood pressure), both alone and in combination with other antihypertensives. It is suitable for a wide range of patients and is recommended as a first-line treatment option in major hypertension guidelines including those from the American College of Cardiology and American Heart Association. Second, it is approved for chronic stable angina — chest pain caused by reduced blood flow to the heart that occurs predictably with exertion. Third, it is approved for vasospastic angina (Prinzmetal's or variant angina), a type of angina caused by coronary artery spasm rather than fixed blockage.

Amlodipine is also commonly included in fixed-dose combination pills for hypertension, paired with ACE inhibitors (as in amlodipine/benazepril, sold as Lotrel) or ARBs (as in amlodipine/valsartan, Exforge) or statins (as in amlodipine/atorvastatin, Caduet).

How Amlodipine Works

Calcium ions play a crucial role in muscle contraction. In vascular smooth muscle, calcium influx through L-type voltage-gated calcium channels triggers contraction, causing blood vessels to narrow (vasoconstrict). Amlodipine blocks these L-type calcium channels in the walls of arteries and arterioles — especially the peripheral arterioles — causing them to relax and dilate. This dilation reduces vascular resistance, which lowers blood pressure.

In the coronary arteries, this same vasodilatory effect increases blood supply to the heart muscle, which reduces the oxygen demand imbalance responsible for angina. Unlike beta-blockers, amlodipine does not significantly slow the heart rate or reduce cardiac output at therapeutic concentrations — its primary action is on peripheral and coronary vascular smooth muscle.

Amlodipine's unusually long half-life is a clinical advantage: blood levels remain stable throughout the day, avoiding the peaks and troughs that can cause rebound hypertension or heart rate fluctuations. Missed doses are less disruptive compared to shorter-acting calcium channel blockers.

Common Side Effects

• Peripheral edema — swelling of the ankles, feet, and lower legs (the most common side effect; occurs in 10–20% of patients and is more common at higher doses and in women)
• Flushing (warmth, redness, or tingling sensation in the face, neck, or chest)
• Headache
• Dizziness
• Fatigue
• Palpitations
• Nausea (uncommon)
• Gingival hyperplasia (gum overgrowth) — a class effect of calcium channel blockers, more common with nifedipine but can occur with amlodipine

Important Warnings

Amlodipine is generally safe during breastfeeding based on limited data, but its safety in pregnancy is less established — it is classified as FDA pregnancy category C. It should be used during pregnancy only if the potential benefit justifies the risk.

Key Drug Interactions

Amlodipine is metabolized by CYP3A4. Strong CYP3A4 inhibitors — including clarithromycin, itraconazole, ritonavir, and grapefruit juice — can increase amlodipine blood levels, potentially causing excessive blood pressure lowering. CYP3A4 inducers like rifampin can reduce amlodipine's effectiveness. Simvastatin interaction is notable: when amlodipine is co-administered with simvastatin, simvastatin levels are increased, raising the risk of myopathy (muscle damage). The FDA recommends limiting the simvastatin dose when combined with amlodipine. Cyclosporine blood levels may also increase with amlodipine, requiring monitoring. Combining amlodipine with other antihypertensives or vasodilators (including PDE5 inhibitors) can have additive blood pressure-lowering effects.

Frequently Asked Questions

Why do my ankles swell on amlodipine?

Peripheral edema from amlodipine is not caused by heart or kidney failure — it results from the drug's mechanism. By dilating arterioles (small arteries), amlodipine increases capillary pressure, which pushes fluid from the bloodstream into the surrounding tissue, particularly in the lower legs where gravity compounds the effect. This is a local vascular effect and does not indicate fluid retention by the kidneys or a failing heart. Elevating the legs can reduce discomfort, and switching to a different class of blood pressure medication may resolve it entirely if it is bothersome.

Can amlodipine be taken at any time of day?

Yes — amlodipine can generally be taken at any time of day, with or without food. Because of its long half-life, the timing is less critical than with shorter-acting medications. Some patients take it at bedtime to minimize any daytime flushing or dizziness. Consistency matters more than specific timing — taking it at the same time each day helps establish a routine.

Is amlodipine safe long-term?

Amlodipine has an extensive long-term safety record. Major cardiovascular outcome trials, including ALLHAT and ACCOMPLISH, have demonstrated that amlodipine-based therapy reduces the risk of heart attack, stroke, and cardiovascular death in hypertensive patients. There is no evidence of harm from long-term use at therapeutic concentrations. Patients may stay on it indefinitely as part of a blood pressure management plan.

Does amlodipine protect the heart beyond just lowering blood pressure?

Evidence suggests yes, to some degree. Amlodipine reduces coronary artery spasm, improves exercise tolerance in stable angina, and has been shown in some studies to slow the progression of atherosclerosis (coronary plaque buildup). The CAMELOT trial demonstrated that amlodipine slowed progression of coronary artery disease in patients with normal blood pressure, suggesting direct anti-atherosclerotic effects beyond blood pressure reduction alone.